Prescient Acquires Dolon, to Enhance Its Strategic Pricing and Market Access Capabilities and Expertise Across the Drug Lifecycle.
Prescient (Prescient Healthcare Group) has acquired London-based pricing and market access consultancy Dolon, strengthening its ability to support global biopharma companies navigating increasingly complex and interconnected clinical, commercial and market access environments.
